Alps Advisors Inc Lian Bio Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.87 - $3.0 $10,730 - $17,214	-5,738 Reduced 8.93%	58,490 $116,000
Q2 2022 Aug 11, 2022	SELL	$2.15 - $6.01 $98,880 - $276,405	-45,991 Reduced 41.73%	64,228 $139,000
Q1 2022 May 16, 2022	SELL	$2.8 - $6.21 $32,471 - $72,017	-11,597 Reduced 9.52%	110,219 $409,000
Q4 2021 Feb 09, 2022	BUY	$6.14 - $16.2 $747,950 - $1.97 Million	121,816 New	121,816 $750,000

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.